Coya Therapeutics paid its 4 named executives $6.4M in total in FY2025 (Dec). CEO Arun Swaminathan was paid $2.1M of that.
Pay$100 in the stock at the end of FY22 → $122
Pay of each named executive
Arun SwaminathanChief Executive Officer, Director
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Howard BermanFormer Chief Executive Officer, Former Executive Chairman of the Board
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Fred GrossmanPresident, Chief Medical Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
David SnyderChief Financial Officer and Chief Operating Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.